Evidence map›Paper›PMID 31932720›Full record

ArticleNature chemical biology2020

Lipid droplets can promote drug accumulation and activation.

Ramin Dubey, Craig E Stivala, Huy Quoc Nguyen, Young-Hwa Goo, Antoni Paul, Jan E Carette, Barry M Trost, Rajat Rohatgi

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Lipid Droplets in Cancer: New Insights and Therapeutic Potential.International journal of molecular sciences · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. The expanding organelle lipidomes: current knowledge and challenges.Cellular and molecular life sciences : CMLS · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ramin DubeyDepartment of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-0687-5831
Craig E StivalaDepartment of Chemistry, Stanford University, Stanford, CA, USA.
Huy Quoc NguyenGenentech, South San Francisco, CA, USA.
Young-Hwa GooDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, USA.ORCID http://orcid.org/0000-0003-1680-1569
Antoni PaulDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, USA.
Jan E CaretteDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-5187-8070
Barry M TrostDepartment of Chemistry, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-7369-9121
Rajat RohatgiDepartment of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA. rrohatgi@stanford.edu.ORCID http://orcid.org/0000-0001-7609-8858
Stanford University · USAlbany Medical Center Hospital · USStanford Medicine · US

Funding

Supplement application for an Olympus automated microscopeR35GM118082 · NIGMS · STANFORD UNIVERSITY · PI RAJAT ROHATGI · 2016 to 2026
$7.6M
Reconstructing Primary CiliaDP2GM105448 · NIGMS · STANFORD UNIVERSITY · PI ROHATGI, RAJAT · 2012 to 2012
$2.4M
Genetic screens to find critical host factors for SARS-CoV-2 infectionR01AI140186 · NIAID · STANFORD UNIVERSITY · PI CARETTE, JAN E · 2019 to 2023
$2.3M
Genetic approaches to discover host factors critical to dengue virus infectionDP2AI104557 · NIAID · STANFORD UNIVERSITY · PI CARETTE, JAN E · 2012 to 2012
$2.3M
Host Genes Critical for Flavivirus InfectionR01AI141970 · NIAID · STANFORD UNIVERSITY · PI CARETTE, JAN E · 2019 to 2023
$2.0M
American Heart Association-American Stroke Association 18TPA34230086NIAID NIH HHS DP2 AI104557NIAID NIH HHS R01 AI140186NIAID NIH HHS R01 AI141970NIGMS NIH HHS DP2 GM105448NIGMS NIH HHS R35 GM118082
6 · The paper itself

Abstract

Genetic screens in cultured human cells represent a powerful unbiased strategy to identify cellular pathways that determine drug efficacy, providing critical information for clinical development. We used insertional mutagenesis-based screens in haploid cells to identify genes required for the sensitivity to lasonolide A (LasA), a macrolide derived from a marine sponge that kills certain types of cancer cells at low nanomolar concentrations. Our screens converged on a single gene, LDAH, encoding a member of the metabolite serine hydrolase family that is localized on the surface of lipid droplets. Mechanistic studies revealed that LasA accumulates in lipid droplets, where it is cleaved into a toxic metabolite by LDAH. We suggest that selective partitioning of hydrophobic drugs into the oil phase of lipid droplets can influence their activation and eventual toxicity to cells.

Indexed as

Cell Line, TumorCell MembraneDrug Evaluation, PreclinicalHaploidyHumansInactivation, MetabolicLipid DropletsMacrolidesProteinslasonolide ALDAH protein, humanMacrolidesProteins

Identifiers

PMID31932720
PMCPMC6989039
OpenAlexW2999742058

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.